Literature DB >> 25628343

24(S)-Hydroxycholesterol as a Modulator of Neuronal Signaling and Survival.

Min-Yu Sun1, Andrew J Linsenbardt1, Christine M Emnett1, Lawrence N Eisenman2, Yukitoshi Izumi3, Charles F Zorumski4, Steve Mennerick5.   

Abstract

The major cholesterol metabolite in brain, 24(S)-hydroxycholesterol (24S-HC), serves as a vehicle for cholesterol removal. Its effects on neuronal function, however, have only recently begun to be investigated. Here, we review that nascent work. Our own studies have demonstrated that 24S-HC has potent positive modulatory effects on N-methyl-d-aspartate (NMDA) receptor (NMDAR) function. This could have implications not only for brain plasticity but also for pathological NMDAR overuse. Other work has demonstrated effects of 24S-HC on neuronal survival and as a possible biomarker of neurodegenerative disease. Depending on circumstances, both upregulation/mimicry of 24S-HC signaling and down-regulation/antagonism may have therapeutic potential. We are interested in the possibility that synthetic analogues of 24S-HC with positive effects at NMDARs may hold neurotherapeutic promise, given the role of NMDA receptor hypofunction in certain neuropsychiatric disorders.
© The Author(s) 2015.

Entities:  

Keywords:  Alzheimer’s disease; NMDA; apoptosis; cholesterol. 24(S)-hydroxycholesterol; glutamate

Mesh:

Substances:

Year:  2015        PMID: 25628343      PMCID: PMC4821654          DOI: 10.1177/1073858414568122

Source DB:  PubMed          Journal:  Neuroscientist        ISSN: 1073-8584            Impact factor:   7.519


  83 in total

Review 1.  Niemann-Pick type C: a disorder of cellular cholesterol trafficking.

Authors:  D S Ory
Journal:  Biochim Biophys Acta       Date:  2000-12-15

2.  Interaction between 24-hydroxycholesterol, oxidative stress, and amyloid-β in amplifying neuronal damage in Alzheimer's disease: three partners in crime.

Authors:  Paola Gamba; Gabriella Leonarduzzi; Elena Tamagno; Michela Guglielmotto; Gabriella Testa; Barbara Sottero; Simona Gargiulo; Fiorella Biasi; Alessandro Mauro; José Viña; Giuseppe Poli
Journal:  Aging Cell       Date:  2011-04-05       Impact factor: 9.304

3.  24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia.

Authors:  A Papassotiropoulos; D Lütjohann; M Bagli; S Locatelli; F Jessen; R Buschfort; U Ptok; I Björkhem; K von Bergmann; R Heun
Journal:  J Psychiatr Res       Date:  2002 Jan-Feb       Impact factor: 4.791

4.  The major cholesterol metabolite cholestane-3β,5α,6β-triol functions as an endogenous neuroprotectant.

Authors:  Haiyan Hu; Yuehan Zhou; Tiandong Leng; Ailing Liu; Youqiong Wang; Xiuhua You; Jingkao Chen; Lipeng Tang; Wenli Chen; Pengxin Qiu; Wei Yin; Yijun Huang; Jingxia Zhang; Liwei Wang; Hanfei Sang; Guangmei Yan
Journal:  J Neurosci       Date:  2014-08-20       Impact factor: 6.167

5.  Cholesterol-dependent balance between evoked and spontaneous synaptic vesicle recycling.

Authors:  Catherine R Wasser; Mert Ertunc; Xinran Liu; Ege T Kavalali
Journal:  J Physiol       Date:  2006-12-14       Impact factor: 5.182

6.  SNAREs are concentrated in cholesterol-dependent clusters that define docking and fusion sites for exocytosis.

Authors:  T Lang; D Bruns; D Wenzel; D Riedel; P Holroyd; C Thiele; R Jahn
Journal:  EMBO J       Date:  2001-05-01       Impact factor: 11.598

7.  Structural basis of drug binding to CYP46A1, an enzyme that controls cholesterol turnover in the brain.

Authors:  Natalia Mast; Casey Charvet; Irina A Pikuleva; C David Stout
Journal:  J Biol Chem       Date:  2010-07-28       Impact factor: 5.157

Review 8.  Alzheimer's disease as homeostatic responses to age-related myelin breakdown.

Authors:  George Bartzokis
Journal:  Neurobiol Aging       Date:  2009-09-22       Impact factor: 4.673

9.  Neuronal expression and subcellular localization of cholesterol 24-hydroxylase in the mouse brain.

Authors:  Denise M O Ramirez; Stefan Andersson; David W Russell
Journal:  J Comp Neurol       Date:  2008-04-10       Impact factor: 3.215

Review 10.  Epigenetic regulation of cholesterol homeostasis.

Authors:  Steve Meaney
Journal:  Front Genet       Date:  2014-09-24       Impact factor: 4.599

View more
  30 in total

1.  Mapping of the Allosteric Site in Cholesterol Hydroxylase CYP46A1 for Efavirenz, a Drug That Stimulates Enzyme Activity.

Authors:  Kyle W Anderson; Natalia Mast; Jeffrey W Hudgens; Joseph B Lin; Illarion V Turko; Irina A Pikuleva
Journal:  J Biol Chem       Date:  2016-04-07       Impact factor: 5.157

2.  Understanding the links between cardiovascular disease and Parkinson's disease.

Authors:  Judy Potashkin; Xuemei Huang; Claudia Becker; Honglei Chen; Thomas Foltynie; Connie Marras
Journal:  Mov Disord       Date:  2019-09-04       Impact factor: 10.338

3.  Esterification of 24S-OHC induces formation of atypical lipid droplet-like structures, leading to neuronal cell death.

Authors:  Wakako Takabe; Yasuomi Urano; Diep-Khanh Ho Vo; Kimiyuki Shibuya; Masaki Tanno; Hiroaki Kitagishi; Toyoshi Fujimoto; Noriko Noguchi
Journal:  J Lipid Res       Date:  2016-09-19       Impact factor: 5.922

4.  Cholesterol-metabolizing enzyme cytochrome P450 46A1 as a pharmacologic target for Alzheimer's disease.

Authors:  Natalia Mast; Aicha Saadane; Ana Valencia-Olvera; James Constans; Erin Maxfield; Hiroyuki Arakawa; Young Li; Gary Landreth; Irina A Pikuleva
Journal:  Neuropharmacology       Date:  2017-06-24       Impact factor: 5.250

5.  Detection of brain specific cardiolipins in plasma after experimental pediatric head injury.

Authors:  Tamil S Anthonymuthu; Elizabeth M Kenny; Zachary E Hier; Robert S B Clark; Patrick M Kochanek; Valerian E Kagan; Hülya Bayır
Journal:  Exp Neurol       Date:  2019-04-11       Impact factor: 5.330

6.  Association of Rare CYP39A1 Variants With Exfoliation Syndrome Involving the Anterior Chamber of the Eye.

Authors:  Zheng Li; Zhenxun Wang; Mei Chin Lee; Matthias Zenkel; Esther Peh; Mineo Ozaki; Fotis Topouzis; Satoko Nakano; Anita Chan; Shuwen Chen; Susan E I Williams; Andrew Orr; Masakazu Nakano; Nino Kobakhidze; Tomasz Zarnowski; Alina Popa-Cherecheanu; Takanori Mizoguchi; Shin-Ichi Manabe; Ken Hayashi; Shigeyasu Kazama; Kenji Inoue; Yosai Mori; Kazunori Miyata; Kazuhisa Sugiyama; Tomomi Higashide; Etsuo Chihara; Ryuichi Ideta; Satoshi Ishiko; Akitoshi Yoshida; Kana Tokumo; Yoshiaki Kiuchi; Tsutomu Ohashi; Toshiya Sakurai; Takako Sugimoto; Hideki Chuman; Makoto Aihara; Masaru Inatani; Kazuhiko Mori; Yoko Ikeda; Morio Ueno; Daniel Gaston; Paul Rafuse; Lesya Shuba; Joseph Saunders; Marcelo Nicolela; George Chichua; Sergo Tabagari; Panayiota Founti; Kar Seng Sim; Wee Yang Meah; Hui Meng Soo; Xiao Yin Chen; Anthi Chatzikyriakidou; Christina Keskini; Theofanis Pappas; Eleftherios Anastasopoulos; Alexandros Lambropoulos; Evangelia S Panagiotou; Dimitrios G Mikropoulos; Ewa Kosior-Jarecka; Augustine Cheong; Yuanhan Li; Urszula Lukasik; Monisha E Nongpiur; Rahat Husain; Shamira A Perera; Lydia Álvarez; Montserrat García; Héctor González-Iglesias; Andrés Fernández-Vega Cueto; Luis Fernández-Vega Cueto; Federico Martinón-Torres; Antonio Salas; Çilingir Oguz; Nevbahar Tamcelik; Eray Atalay; Bilge Batu; Murat Irkec; Dilek Aktas; Burcu Kasim; Yury S Astakhov; Sergei Y Astakhov; Eugeny L Akopov; Andreas Giessl; Christian Mardin; Claus Hellerbrand; Jessica N Cooke Bailey; Robert P Igo; Jonathan L Haines; Deepak P Edward; Steffen Heegaard; Sonia Davila; Patrick Tan; Jae H Kang; Louis R Pasquale; Friedrich E Kruse; André Reis; Trevor R Carmichael; Michael Hauser; Michele Ramsay; Georg Mossböck; Nilgun Yildirim; Kei Tashiro; Anastasios G P Konstas; Miguel Coca-Prados; Jia Nee Foo; Shigeru Kinoshita; Chie Sotozono; Toshiaki Kubota; Michael Dubina; Robert Ritch; Janey L Wiggs; Francesca Pasutto; Ursula Schlötzer-Schrehardt; Ying Swan Ho; Tin Aung; Wai Leong Tam; Chiea Chuen Khor
Journal:  JAMA       Date:  2021-02-23       Impact factor: 56.272

Review 7.  LXR Regulation of Brain Cholesterol: From Development to Disease.

Authors:  Rebecca Courtney; Gary E Landreth
Journal:  Trends Endocrinol Metab       Date:  2016-04-21       Impact factor: 12.015

8.  Inhibitors of cellular stress overcome acute effects of ethanol on hippocampal plasticity and learning.

Authors:  Yukitoshi Izumi; Charles F Zorumski
Journal:  Neurobiol Dis       Date:  2020-04-22       Impact factor: 5.996

9.  Visualizing pregnenolone sulfate-like modulators of NMDA receptor function reveals intracellular and plasma-membrane localization.

Authors:  Mariangela Chisari; Timothy J Wilding; Samuel Brunwasser; Kathiresan Krishnan; Mingxing Qian; Ann Benz; James E Huettner; Charles F Zorumski; Douglas F Covey; Steven Mennerick
Journal:  Neuropharmacology       Date:  2018-10-15       Impact factor: 5.250

10.  Preferential enhancement of GluN2B-containing native NMDA receptors by the endogenous modulator 24S-hydroxycholesterol in hippocampal neurons.

Authors:  Xiaofei Wei; Toshiya Nishi; Shinichi Kondou; Haruhide Kimura; Istvan Mody
Journal:  Neuropharmacology       Date:  2018-12-27       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.